DrugPatentWatch Database Preview
NPLATE Drug Profile
Summary for Tradename: NPLATE
| Patents: | 18 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for NPLATE
| Mechanism of Action | Thrombopoietin Receptor Agonists |
| Physiological Effect | Increased Megakaryocyte Maturation Increased Platelet Production |
US Patents for NPLATE
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | Astellas Institute for Regenerative Medicine (Marlborough, MA) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | Astellas Institute for Regenerative Medicine (Marlborough, MA) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | Bayer Intellectual Property GmbH (Monheim, DE) | ➤ Try a Free Trial | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Try a Free Trial | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for NPLATE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Poland | 211164 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0024770 | ➤ Try a Free Trial |
| Hungary | 228582 | ➤ Try a Free Trial |
| Japan | 3820105 | ➤ Try a Free Trial |
| Canada | 2346996 | ➤ Try a Free Trial |
| European Patent Office | 2549863 | ➤ Try a Free Trial |
| Slovenia | 1783222 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for NPLATE
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2009006 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: ROMIPLOSTIMUM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204 |
| 25/2009 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ROMIPLOSTIM |
| 2009000039 | Germany | ➤ Try a Free Trial | PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204 |
| C/GB09/035 | United Kingdom | ➤ Try a Free Trial | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB09/035 GRANTED TO KIRIN-AMGEN INC. IN RESPECT OF THE PRODUCT ROMIPLOSTIM, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6361 DATED 20/04/2011 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 05/02/2024. |
| 09/022 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204 |
| 6 | Finland | ➤ Try a Free Trial | |
| 0398 | Netherlands | ➤ Try a Free Trial | 300398, 20191022, EXPIRES: 20240203 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
